Subcutaneous and Deep Mycoses

  • Marc E. Grossman
  • Lindy P. Fox
  • Carrie Kovarik
  • Misha Rosenbach


Invasive aspergillosis is the most common opportunistic fungal infection in the hematopoetic stem cell transplant patient. Prior to the regular use of antifungal prophylaxis, invasive fungal infections caused by Candida were the most common infection, followed by infection by Aspergillus.1 In the 1990s, 90% of Aspergillus infections were due to A. fumigatus; however A. flavus, A. terreus, A. niger, and A. versicolor are all potential causes of invasive aspergillosis. A. flavus, followed by A. niger, is the most common cause of primary cutaneous disease while A. fumigatus more commonly causes disseminated disease.2 A. glaucus, A. chevalieri, and A. ustus are rare causes of cutaneous disease.3


Invasive Aspergillosis Acquire Immune Deficiency Syndrome Graft Versus Host Disease Necrotizing Fasciitis Acquire Immune Deficiency Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



  1. 1.
    Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology. 2011;3:175–191.Google Scholar
  2. 2.
    Nenoff P, Kliem C, Mittag M, et al. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur J Dermatol. 2002;12:93–8.PubMedGoogle Scholar
  3. 3.
    Roilides E, Farmaki E. Human immunodeficiency virus infection and cutaneous Aspergillosis. Arch Derm. 2000;136:412–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Murakawa GJ, Harvell JD, Lubitz P, et al. Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Derm. 2000;136:365–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infection in haematopoietic stem cell transplant recipients. Br J Hematol. 2007;139:519–31.CrossRefGoogle Scholar
  6. 6.
    Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41:521–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Walsh TJ. Primary cutaneous aspergillosis – an emerging infection among immunocompromised patients. Clin Infect Dis. 1998;27:453–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Richards KA, Mancini AJ. A painful erythematous forearm nodule in a girl with Hodgkin disease. Diagnosis: primary cutaneous aspergillosis. Arch Dermatol. 2000;136(9):1165–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Grossman ME, Fithian EC, Behrens C, et al. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol. 1985;12:313–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Munn S, Keane F, Child F, Philpott-Howard J, Du Vivier A. Primary cutaneous aspergillosis. Br J Dermatol. 1999;141:378–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Ricci RM, Evans JS, Meffert JJ, Kaufman L, Sadkowski LC. Primary cutaneous Aspergillus ustus infection: second reported case. J Am Acad Dermatol. 1998;38(5 Pt 2):797–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Chakrabarti A, Gupta V, Biswas G, Kumar B, Sakhuja VK. Primary cutaneous aspergillosis: our experience in 10 years. J Infect. 1998;37:24–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Vennewald I, Wollina U. Cutaneous infection due to opportunistic molds: uncommon presentations. Clin Dermatol. 2005;23:565–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Park SB, Kang MJ, Whang EA, et al. A case of primary cutaneous aspergillosis in a renal transplant recipient. Transplant Proc. 2004;36:2156–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Thakur BK, Bernardi DM, Murali MR, McClain SA, Clark RA. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris. J Amer Acad Dermatol. 1998;38:488–90.CrossRefGoogle Scholar
  16. 16.
    Mori T, Takae Y, Izaki S, et al. Cutaneous aspergillosis in a patient with follicular lymphoma. Eur J Dermatol. 2003;13:102–3.PubMedGoogle Scholar
  17. 17.
    Correa ME, Soares AB, de Souza CA, et al. Primary aspergillosis affecting the tongue of a leukemic patient. Oral Dis. 2003;9:49–53.CrossRefPubMedGoogle Scholar
  18. 18.
    D’Antonio D, Pagano L, Girmenia C, et al. Cutaneous aspergillosis in patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2000;19:362–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Palmero ML, Pope E, Brophy J. Sporotrichoid aspergillosis in an immunocompromised child: a case report and review of the literature. Pediatr Dermatol. 2009 ;26(5):592–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Geyer AS, Fox LP, Rabinowitz A, Grossman ME. Dehisced wound in a heart transplant recipient. Arch Dermatol. 2005;141(8):1037–40.CrossRefPubMedGoogle Scholar
  21. 21.
    van Burik JA, Colven R, Spach DH. Itraconazole therapy for primary cutaneous aspergillosis in patients with AIDS. Clin Infect Dis. 1998;27:643–4.CrossRefPubMedGoogle Scholar
  22. 22.
    Saadat P, Kappel S, Young S, Abrishami M, Vadmal MS. Aspergillus fumigatus majocchis granuloma in a patient with acquired immunodeficiency syndrome. Clin Exp Dermatol. 2008;33:450–3.CrossRefPubMedGoogle Scholar
  23. 23.
    Stanford D, Boyle M, Gillespie R. Human immunodeficiency virus-related primary cutaneous aspergillosis. Australas J Dermatol. 2000;41:112–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Hunt SJ, Nagi C, Gross KG, Wong DS, Mathews WC. Primary ­cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome. Arch Derm. 1992;128:1229–32.CrossRefPubMedGoogle Scholar
  25. 25.
    Arikan S, Uzun O, Cetinkaya Y, et al. Primary cutaneous aspergillosis in human immunodeficiency virus-infected patients: two cases and review. Clin Infect Dis. 1998;27(3):641–3.CrossRefPubMedGoogle Scholar
  26. 26.
    Schimmelpfennig C, Naumann R, Zuberbier T, et al. Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2001;27:753–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Nenoff P, Kliem C, Mittag M, et al. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur J Dermatol. 2002;12:93–8.PubMedGoogle Scholar
  28. 28.
    Galimberti R, Kowalczuk A, Hidalgo Parra I, Gonzalez Ramos M, Flores V. Cutaneous aspergillosis: a report of six cases. Br J Dermatol. 1998;139:522–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Szyfelbein K, Lin JY, Bellucci KS, Williams JM. Tender erythema of the left lower extremity. Disseminated Aspergillus fumigatus infection with concurrent active cytomegalovirus infection (CMV). Arch Dermatol. 2007;143:535–40.CrossRefPubMedGoogle Scholar
  30. 30.
    Chatzipanagiotou S, Takou K, Perogamvros A. Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses. 1998;41(9–10):379–82.CrossRefPubMedGoogle Scholar
  31. 31.
    Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive Aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109:1119–24.CrossRefPubMedGoogle Scholar
  32. 32.
    Shao PL, Huang LM, Hsueh PR. Invasive fungal infection – laboratory diagnosis and antifungal treatment. J Microbiol Immunol Infect. 2006;39:178–88.PubMedGoogle Scholar


  1. 33.
    Hay RJ. Blastomycosis: what’s new? J Eur Acad Dermatol Venereol. 2000 ;14(4):249–50.CrossRefPubMedGoogle Scholar
  2. 34.
    Bradsher RW. Clinical features of blastomycosis. Semin Respir Infect. 1997;12(3):229–34.PubMedGoogle Scholar
  3. 35.
    Pappas PG. Blastomycosis in the immunocompromised patient. Semin Respir Infect. 1997;12(3):243–51.PubMedGoogle Scholar
  4. 36.
    Cohen P, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.Google Scholar
  5. 37.
    Fisher KR, Baselski V, Beard G, et al. Pustular blastomycosis. J Am Acad Dermatol. 2009;61:355–8.CrossRefPubMedGoogle Scholar
  6. 38.
    Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumor necrosis factor-alpha inhibitor therapy. Drugs. 2009;69:1403–15.CrossRefPubMedGoogle Scholar
  7. 39.
    Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993;16(1):54–8.CrossRefPubMedGoogle Scholar
  8. 40.
    Walker K, Skelton H, Smith K. Cutaneous lesions showing giant yeast forms of Blastomyces dermatitidis. J Cutan Pathol. 2002;29:616–8.CrossRefPubMedGoogle Scholar
  9. 41.
    Lemos LB, Baliga M, Guo M. Blastomycosis: the Great Pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol. 2002;6(3):194–203.CrossRefPubMedGoogle Scholar
  10. 42.
    Gauthier GM, Safdar H, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310–7.CrossRefPubMedGoogle Scholar
  11. 43.
    Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801–12.CrossRefPubMedGoogle Scholar


  1. 44.
    Pedraz J, Delgado-Jiménez Y, Pérez-Gala S, et al. Cutaneous expression of systemic candidiasis. Clin Exp Dermatol. 2009;34:106–10.CrossRefPubMedGoogle Scholar
  2. 45.
    Bougnoux ME, Dupont C, Turner L, et al. Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict. Eur J Clin Microbiol Infect Dis. 1997;16:598–600.CrossRefPubMedGoogle Scholar
  3. 46.
    Kreuter A, Teichmann M, Stuecker M, et al. Generalized fungal ­infection in a patient with AIDS appearing as skin papules. Eur J Med Res. 2003;8:435–7.PubMedGoogle Scholar
  4. 47.
    Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol. 2002;3:19–35.CrossRefPubMedGoogle Scholar
  5. 48.
    Leung AY, Chim CS, Ho PL, et al. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect. 2002;50:316–9.CrossRefPubMedGoogle Scholar
  6. 49.
    Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41:521–6.CrossRefPubMedGoogle Scholar
  7. 50.
    Muñoz P, Sánchez-Somolinos M, Alcalá L, et al. Candida krusei ­fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother. 2005;55:188–93.CrossRefPubMedGoogle Scholar
  8. 51.
    Gunsilius E, Lass-Flörl C, Kähler CM, Gastl G, Petzer AL. Candida ciferrii, a new fluconaozle-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol. 2001;80:178–9.CrossRefPubMedGoogle Scholar
  9. 52.
    Wellinghausen N, Moericke A, Bundschuh S, et al. Multifocal osteomyelitis caused by Candida dubliniensis. J Med Microbiol. 2009;58:386–90.CrossRefPubMedGoogle Scholar
  10. 53.
    Bodey GP. Dermatologic manifestations of infections in neutropenic patients. Infect Dis Clin North Am. 1994;8:655–75.PubMedGoogle Scholar
  11. 54.
    Grossman ME, Silvers DN, Walther RR. Cutaneous manifestations of disseminated candidiasis. J Am Acad Dermatol. 1980;2:111–6.PubMedGoogle Scholar
  12. 55.
    Ruchel R. Clinical presentation of invasive candida mycoses. Mycoses. 1997;40:17–20.CrossRefPubMedGoogle Scholar
  13. 56.
    Wai PH, Ewing CA, Johnson LB, et al. Candida fasciitis following renal transplantation. Transplantation. 2001;72(3):477–9.CrossRefPubMedGoogle Scholar
  14. 57.
    Glaich AS, Krathen RA, Smith MJ, Hsu S. Disseminated candidiasis mimicking leukocytoclastic vasculitis. J Am Acad Dermatol. 2005;53(3):544–6.CrossRefPubMedGoogle Scholar
  15. 58.
    Marcus J, Grossman ME, Yunakov MJ, Rappaport F. Disseminated candidiasis, candida arthritis and unilateral skin lesions. J Am Acad Dermatol. 1992;26:295–7.CrossRefPubMedGoogle Scholar
  16. 59.
    Held JL, Berkowitz RK, Grossman ME. Use of touch preparation for rapid diagnosis of disseminated candidiasis. J Am Acad Dermatol. 1988;19:1063–6.CrossRefPubMedGoogle Scholar
  17. 60.
    Spellberg BJ, Filler SG, Edwards Jr JE. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42(2):244–51. Epub 2005 Dec 2.CrossRefPubMedGoogle Scholar


  1. 61.
    DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol. 2006;55(6):929–42.CrossRefPubMedGoogle Scholar
  2. 62.
    Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119(11):964–9.CrossRefPubMedGoogle Scholar
  3. 63.
    Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004;50(6):1959–66.CrossRefPubMedGoogle Scholar
  4. 64.
    Prichard JG, Sorotzkin RA, James III RE. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis. 1987;39(3):203–5.PubMedGoogle Scholar
  5. 65.
    Stagliano D, Epstein J, Hickey P. Fomite-transmitted coccidioidomycosis in an immunocompromised child. Pediatr Infect Dis J. 2007;26(5):454–6.CrossRefPubMedGoogle Scholar
  6. 66.
    Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6(2):340–5.CrossRefPubMedGoogle Scholar
  7. 67.
    Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987;83(5):949–52.CrossRefPubMedGoogle Scholar
  8. 68.
    Wolf JE, Little JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis. 1986;5(4):331–6.CrossRefPubMedGoogle Scholar
  9. 69.
    Rogan MP, Thomas K. Fatal miliary coccidioidomycosis in a patient receiving infliximab therapy: a case report. J Med Case Rep. 2007;1:79.CrossRefPubMedGoogle Scholar
  10. 70.
    Poonawalla T, Diwan H, Duvic M. Mycosis fungoides with coccidioidomycosis. Clin Lymphoma Myeloma. 2006;7(2):148–50.CrossRefPubMedGoogle Scholar
  11. 71.
    Ugurlu S, de Alba Campomanes AG, Naseri A, Blair JE, McLeish WM. Coccidioidomycosis of the eyelid. Ophthal Plast Reconstr Surg. 2005;21(2):157–9.CrossRefPubMedGoogle Scholar
  12. 72.
    Gold WL, Campbell I, Vellend H. Disseminated coccidioidomycosis in a Canadian patient with chronic HIV infection – Ontario. Can Commun Dis Rep. 1992;18(19):149–50.PubMedGoogle Scholar
  13. 73.
    Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci. 2007;1111:365–76.CrossRefPubMedGoogle Scholar
  14. 74.
    Ampel NM. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART). Semin Respir Infect. 2001;16(4):257–62.CrossRefPubMedGoogle Scholar


  1. 75.
    Narayan S, Batta K, Colloby P, Tan CY. Cutaneous Cryptococcus infection due to C. albidus associated with SeÂzary syndrome. Br J Dermatol. 2000;143:632–4.CrossRefPubMedGoogle Scholar
  2. 76.
    Cohen P, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.Google Scholar
  3. 77.
    Sing Y, Ramdial PK. Cryptococcal inflammatory pseudotumors. Am J Surg Pathol. 2007;31:1521–7.CrossRefPubMedGoogle Scholar
  4. 78.
    França AV, Carneiro M, dal Sasso K, Souza Cda S, Martinelli A. Cryptococcosis in cirrhotic patients. Mycoses. 2005;48:68–72.CrossRefPubMedGoogle Scholar
  5. 79.
    Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375–81.PubMedGoogle Scholar
  6. 80.
    Orsini J, Nowakowski J, Delaney V, Sakoulas G, Wormser GP. Cryptococcal infection presenting as cellulitis in a renal transplant recipient. Transpl Infect Dis. 2009;11:68–71.CrossRefPubMedGoogle Scholar
  7. 81.
    Moe K, Lotsikas-Baggili AJ, Kupiec-Banasikowska A, Kauffman CL. The cutaneous predilection of disseminated cryptococcal infection in organ transplant recipients. Arch Dermatol. 2005;141(7):913–4.CrossRefPubMedGoogle Scholar
  8. 82.
    Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol. 2003;41(3):177–88.CrossRefPubMedGoogle Scholar
  9. 83.
    Wilson ML, Sewell LD, Mowad CM. Case reports: primary cutaneous Cryptoccocosis during therapy with methotrexate and adalimumab. J Drugs Dermatol. 2008;7:53–4.PubMedGoogle Scholar
  10. 84.
    Hoang JK, Burruss J. Localized cutaneous Cryptococcus albidus. Infection in a 14-year-old boy on etanercept therapy. Pediatr Dermatol. 2007;24(3):285–8.CrossRefPubMedGoogle Scholar
  11. 85.
    Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Derm. 1996;132:545–8.CrossRefPubMedGoogle Scholar
  12. 86.
    Sánchez P, Bosch RJ, de Gálvez MV, Gallardo MA, Herrera E. Cutaneous cryptococcosis in two patients with acquired immunodeficiency syndrome. Int J STD AIDS. 2000;11:477–80.CrossRefPubMedGoogle Scholar
  13. 87.
    Gasiorowski J, Knysz B, Szetela B, Gładysz A. Cutaneous cryptococcosis as a rare manifestation of the immune reconstitution syndrome in an HIV-1-infected patient. Postepy Hig Med Dosw (Online). 2008;62:1–3.Google Scholar
  14. 88.
    Vandersmissen G, Meuleman L, Tits G, Verhaeghe A, Peetermans WE. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin Belg. 1996;51(2):111–7.PubMedGoogle Scholar
  15. 89.
    Adachi M, Tsuruta D, Imanishi H, Ishii M, Kobayashi H. Necrotizing fasciitis caused by Cryptococcus neoformans in a patient with pemphigus vegetans. Clin Exp Dermatol. 2009;34(8):751–3.CrossRefGoogle Scholar
  16. 90.
    Başaran O, Emiroğlu R, Arikan U, Karakayali H, Haberal M. Cryptococcal necrotizing fasciitis with multiple sites of involvement in the lower extremities. Dermatol Surg. 2003;29(11):1158–60.CrossRefPubMedGoogle Scholar
  17. 91.
    Baer S, Baddley JW, Gnann JW, Pappas PG. Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients. Transpl Infect Dis. 2009;11(4):353–8.CrossRefPubMedGoogle Scholar
  18. 92.
    Carbia SG, Chain M, Acuña K, et al. Disseminated cryptococcosis with cutaneous lesions complicating steroid therapy for Behçet’s disease. Int J Dermatol. 2003;42:816–8.CrossRefGoogle Scholar
  19. 93.
    Blocher KS, Weeks JA, Noble RC. Cutaneous cryptococcal infection presenting as vulvar lesion. Genitourin Med. 1987;63:341–3.PubMedGoogle Scholar
  20. 94.
    Ebara N, Kobayashi N, Asaka H, et al. Localized cutaneous cryptococcosis in a patient with chronic myeloproliferative disease. J Dermatol. 2005;32(8):674–6.PubMedGoogle Scholar
  21. 95.
    Manfredi R, Mazzoni A, Nanetti A, et al. Morphologic features and clinical significance of skin involvement in patients with AIDS-related cryptococcosis. Acta Derm Venereol. 1996;76(1):72–4.PubMedGoogle Scholar
  22. 96.
    Dimino-Emme L, Gurevitch AW. Cutaneous manifestations of disseminated cryptococcosis. J Am Acad Dermatol. 1995;32:844–50.CrossRefPubMedGoogle Scholar
  23. 97.
    Calista D, Grosso C. Cutaneous cryptococcosis of the penis. Dermatol Online J. 2008;14(7):9.PubMedGoogle Scholar
  24. 98.
    Hecker MS, Weinberg JM. Cutaneous cryptococcosis mimicking keloid. Dermatology. 2001;202:78–9.CrossRefPubMedGoogle Scholar
  25. 99.
    Murakawa GJ, Mauro TM, Egbert B. Disseminated cutaneous Cryptococcus clinically mimicking basal cell carcinoma. Dermatol Surg. 1995;21(11):992–3.PubMedGoogle Scholar
  26. 100.
    Ingleton R, Koestenblatt E, Don P, et al. Cutaneous cryptococcosis mimicking basal cell carcinoma in a patient with AIDS. J Cutan Med Surg. 1998;3(1):43–5.PubMedGoogle Scholar
  27. 101.
    Annam V, Inamadar AC, Palit A, Yelikar BR. Co-infection of molluscum contagiosum virus and cryptococcosis in the same skin lesion in a HIV-infected patient. J Cutan Pathol. 2008;35 Suppl 1:29–31.CrossRefPubMedGoogle Scholar
  28. 102.
    Myers SA, Kamino H. Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. J Am Acad Dermatol. 1996;34:898–900.CrossRefPubMedGoogle Scholar
  29. 103.
    Neuville S, Dromer F, Morin O, et al. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis. 2003;36:337–47.CrossRefPubMedGoogle Scholar
  30. 104.
    Zorman JV, Zupanc TL, Parač Z, Cuček I. Primary cutaneous crypto­­coccosis in a renal transplant recipient: case report. Mycoses. 2010;53(6):535–7.CrossRefPubMedGoogle Scholar
  31. 105.
    Hunger RE, Paredes BE, Quattroppani C, Krähenbühl S, Braathen LR. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology. 2000;200:352–5.CrossRefPubMedGoogle Scholar
  32. 106.
    Baumgarten KL, Valentine VG, Garcia-Diaz JB. Primary cutaneous cryptococcosis in a lung transplant recipient. South Med J. 2004;97:692–5.CrossRefPubMedGoogle Scholar
  33. 107.
    Badreshia S, Klepeiss S, Ioffreda M, et al. Cutaneous cryptococcus in an elderly woman with chronic essential dermatitis. Cutis. 2006;78:53–6.PubMedGoogle Scholar
  34. 108.
    Romano C, Taddeucci P, Donati D, Miracco C, Massai L. Primary cutaneous cryptococcosis due to Cryptococcus neoformans in a woman with non-Hodgkin’s lymphoma. Acta Dermatol Venerol. 2001;8:220–1.Google Scholar
  35. 109.
    Bohne T, Sander A, Pfister-Wartha A, Schöpf E. Primary cutaneous cryptococcosis following trauma of the right forearm. Mycoses. 1996;39(11–12):457–9.CrossRefPubMedGoogle Scholar
  36. 110.
    Ramdial PK, Calonje E, Sing Y, Chotey NA, Aboobaker J. Molluscum-like cutaneous cryptococcosis: a histopathological and pathogenetic appraisal. J Cutan Pathol. 2008;35:1007–13.CrossRefPubMedGoogle Scholar


  1. 111.
    Bonifaz A, Chang P, Moreno K, Fernández-Fernández V, et al. Disseminated cutaneous histoplasmosis in acquired immunodeficiency syndrome: report of 23 cases. Clin Exp Dermatol. 2009;34(4):481–6.CrossRefPubMedGoogle Scholar
  2. 112.
    Couppié P, Clyti E, Nacher M, et al. Acquired immunodeficiency syndrome-related oral and/or cutaneous histoplasmosis: a descriptive and comparative study of 21 cases in French Guiana. Int J Dermatol. 2002;41:571–6.CrossRefPubMedGoogle Scholar
  3. 113.
    Cohen PR, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.Google Scholar
  4. 114.
    Cohen PR, Grossman ME, Silvers DN. Disseminated histoplasmosis and human immunodeficiency virus infection. Int J Dermatol. 1991;30(9):614–22.CrossRefPubMedGoogle Scholar
  5. 115.
    Cohen PR, Bank DE, Silvers DN, Grossman ME. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol. 1990;23(3 Pt 1):422–8.CrossRefPubMedGoogle Scholar
  6. 116.
    Cunha VS, Zampese MS, Aquino VR, Cestari TF, Goldani LZ. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol. 2007;32:250–5.CrossRefPubMedGoogle Scholar
  7. 117.
    Cohen PR, Held JL, Grossman ME, Ross MJ, Silvers DN. Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis. Int J Dermatol. 1991;30(2):104–8.CrossRefPubMedGoogle Scholar
  8. 118.
    Kucharski LD, Dal Pizzol AS, Fillus J Neto, et al. Disseminated cutaneous histoplasmosis and AIDS: case report. Braz J Infect Dis. 2000;4(5):255–61.Google Scholar
  9. 119.
    Kalter DC, Tschen JA, Klima M. Maculopapular rash in a patient with acquired immunodeficiency syndrome. Disseminated histoplasmosis in acquired immunodeficiency syndrome (AIDS). Arch Dermatol. 1985;121(11):1455–6, 1458–9.CrossRefPubMedGoogle Scholar
  10. 120.
    Laochumroonvorapong P, DiCostanzo DP, Wu H, et al. Disseminated histoplasmosis presenting as pyoderma gangrenosum-like lesions in a patient with acquired immunodeficiency syndrome. Int J Dermatol. 2001;40(8):518–21.CrossRefPubMedGoogle Scholar
  11. 121.
    K Ramdial P, Mosam A, Dlova NC, et al. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2002;29:215–25.Google Scholar
  12. 122.
    Chaker BM, Cockerell CJ. Concomitant psoriasis, seborrheic dermatitis, and disseminated cutaneous histoplasmosis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol. 1993;29(2 Pt 2):311–3.CrossRefPubMedGoogle Scholar
  13. 123.
    Abildgaard Jr WH, Hargrove RH, Kalivas J. Histoplasma panniculitis. Arch Dermatol. 1985;121(7):914–6.CrossRefPubMedGoogle Scholar
  14. 124.
    Rosenberg JD, Scheinfeld NS. Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome. Cutis. 2003;72(6):439–45.PubMedGoogle Scholar
  15. 125.
    Cole MC, Cohen PR, Satra KH, Grossman ME. The concurrent presence of systemic disease pathogens and cutaneous Kaposi’s sarcoma in the same lesion: histoplasma capsulatum and Kaposi’s sarcoma coexisting in a single skin lesion in a patient with AIDS. J Am Acad Dermatol. 1992;26(2 Pt 2):285–7.CrossRefPubMedGoogle Scholar
  16. 126.
    Myers SA, Kamino H. Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. J Am Acad Dermatol. 1996;34:898–900.CrossRefPubMedGoogle Scholar
  17. 127.
    Cole MC, Grossman ME. Disseminated histoplasmosis presenting as tongue nodules in an HIV infected patient. Cutis. 1995;55:104–6.PubMedGoogle Scholar
  18. 128.
    Casariego Z, Kelly GR, Perez H, et al. Disseminated histoplasmosis with orofacial involvement in HIV-1-infected patients with AIDS: manifestations and treatment. Oral Dis. 1997;3:184–7.CrossRefPubMedGoogle Scholar
  19. 129.
    Barton EN, Roberts L, Ince WE, et al. Cutaneous histoplasmosis in the acquired immune deficiency syndrome – a report of three cases from Trinidad. Trop Geogr Med. 1988;40(2):153–7.PubMedGoogle Scholar
  20. 130.
    de Oliveira EV, Miduati FB, Antonio JR, et al. Histoplasmosis as cause of penile ulcer in acquired immune deficiency syndrome (AIDS): three case reports. Mycopathologia. 2007;164:295–9.CrossRefPubMedGoogle Scholar
  21. 131.
    Rodríguez G, Ordóñéz N, Motta A. Histoplasma capsulatum var. capsulatum within cutaneous nerves in patients with disseminated histoplasmosis and AIDS. Br J Dermatol. 2001;144(1):205–7.CrossRefPubMedGoogle Scholar
  22. 132.
    Paul AY, Aldrich S, Scott RS, Ellis MW. Disseminated histoplasmosis in a patient with AIDS: case report and review of the literature. Cutis. 2007;80(4):309–12.PubMedGoogle Scholar
  23. 133.
    Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS. 2006;20(1):119–21.CrossRefPubMedGoogle Scholar


  1. 134.
    Foulet F, Duvoux C, de Bièvre C, Hézode C, Bretagne S. Cutaneous phaeohyphomycosis caused by Veronaea bothryosa in a liver transplant recipient successfully treated with itraconazole. Clin Infect Dis. 1999;29(3):689–90.CrossRefPubMedGoogle Scholar
  2. 135.
    Liou JM, Wang JT, Wang MH, Wang SS, Hsueh PR. Phaeohyphomycosis caused by Exophiala species in immunocompromised hosts. J Formos Med Assoc. 2002;101(7):523–6.PubMedGoogle Scholar
  3. 136.
    Umemoto N, Demitsu T, Kakurai M, et al. Two cases of cutaneous phaeohyphomycosis due to exophiala jeanselmei: diagnostic significance of direct microscopic examination of the purpulent discharge. Clin Exp Dermatol. 2009;34(7):e351–3.CrossRefPubMedGoogle Scholar
  4. 137.
    Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24(3):369–74.CrossRefPubMedGoogle Scholar
  5. 138.
    Saint-Jean M, St-Germain G, Laferrière C, Tapiero B. Hospital-acquired phaeohyphomycosis due to Exserohilum rostratum in a child with leukemia. Can J Infect Dis Med Microbiol. 2007;18(3):200–2.PubMedGoogle Scholar
  6. 139.
    Sutton DA, Rinaldi MG, Kielhofner M. First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J Clin Microbiol. 2004;42:2843–6.CrossRefPubMedGoogle Scholar
  7. 140.
    Gerdsen R, Uerlich M, De Hoog GS, Bieber T, Horré R. Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol. 2001;154:484–6.CrossRefGoogle Scholar
  8. 141.
    Calabrò G, Nino M, Gallo L, Scalvenzi M. Cutaneous alternariosis in a kidney transplantation recipient: report of a case. J Dermatolog Treat. 2008;19:246–8.CrossRefPubMedGoogle Scholar
  9. 142.
    Lin SC, Sun PL, Ju YM, Chan YJ. Cutaneous phaeohyphomycosis caused by Exserohilum rostratum in a patient with cutaneous T cell lymphoma. Int J Dermatol. 2009;48:295–8.CrossRefPubMedGoogle Scholar
  10. 143.
    Segner S, Jouret F, Durant JF, Marot L, Kanaan N. Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transpl Infect Dis. 2009;11:330–2.CrossRefPubMedGoogle Scholar
  11. 144.
    Martínez-González MC, Verea MM, Velasco D, et al. Three cases of cutaneous phaeohyphomycosis by Exophiala jeanselmei. Eur J Dermatol. 2008;18(3):313–6.PubMedGoogle Scholar
  12. 145.
    Brasch J, Busch JO, de Hoog GS. Cutaneous phaeohyphomycosis caused by Alternaria infectoria. Acta Derm Venereol. 2008;88:160–1.CrossRefPubMedGoogle Scholar
  13. 146.
    Romano C, Bilenchi R, Alessandrini C, Miracco C. Case report. Cutaneous phaeohyphomycosis caused by Cladosporium oxysporum. Mycoses. 1999;42:111–5.CrossRefPubMedGoogle Scholar
  14. 147.
    Gené J, Azón-Masoliver A, Guarro J, et al. Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient. J Clin Microbiol. 1995;33:2774–6.PubMedGoogle Scholar
  15. 148.
    Harris JE, Sutton DA, Rubin A, et al. Exophiala spinifera as a cause of cutaneous phaeohyphomycosis: case study and review of the literature. Med Mycol. 2009;47(1):87–93.CrossRefPubMedGoogle Scholar
  16. 149.
    Dubois D, Pihet M, Clec’h CL, et al. Cutaneous phaeohyphomycosis due to Alternaria infectoria. Mycopathologica. 2005;160:117–23.CrossRefGoogle Scholar
  17. 150.
    Yehia M, Thomas M, Pilmore H, Van Der Merwe W, Dittmer I. Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients: three cases. Transplantation. 2004;77:140–2.CrossRefPubMedGoogle Scholar
  18. 151.
    McCown HF, Sahn EE. Subcutaneous phaeohyphomycosis and nocardiosis in a kidney transplant patient. J Am Acad Dermatol. 1997;36(5 Pt 2):863–6.CrossRefPubMedGoogle Scholar
  19. 152.
    Arnoldo BD, Purdue GF, Tchorz K, Hunt JL. A case report of phaeohyphomycosis caused by Cladophialophora bantiana treated in a burn unit. J Burn Care Rehabil. 2005;26:285–7.PubMedGoogle Scholar
  20. 153.
    O’Quinn RP, Hoffmann JL, Boyd AS. Colletotrichum species as emerging opportunistic fungal pathogens: a report of 3 cases of phaeohyphomycosis and review. J Am Acad Dermatol. 2001;45(1):56–61.CrossRefPubMedGoogle Scholar
  21. 154.
    Pereiro Jr M, Pereiro Ferreirós MM, De Hoog GS, Toribio J. Cutaneous infection caused by Alternaria in patients receiving tacrolimus. Med Mycol. 2004;42(3):277–82.CrossRefPubMedGoogle Scholar
  22. 155.
    Mayser P, Nilles M, de Hoog GS. Case report. Cutaneous phaeohyphomycosis due to Alternaria alternata. Mycoses. 2002; 45(8):338–40.CrossRefPubMedGoogle Scholar
  23. 156.
    Al-Attar A, Williams CG, Redett RJ. Rare lower extremity invasive fungal infection of an immunosuppressed patient: Exserohilum longirostratum. Plast Reconstr Surg. 2006;117(3):44e–7e.CrossRefPubMedGoogle Scholar
  24. 157.
    Chen YT, Lin HC, Huang CC, Lo YH. Cutaneous phaeohyphomycosis caused by an Itraconazole and Amphotericin B resistant strain of Veronaeae botryose. Int J Dermatol. 2006;45:429–32.CrossRefPubMedGoogle Scholar
  25. 158.
    Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467–76.CrossRefPubMedGoogle Scholar
  26. 159.
    Ohira S, Isoda K, Hamanaka H, et al. Case report. Phaeo­hyphomycosis caused by Phialophera verrucosa developed in a patient with non-HIV acquired immunodeficiency syndrome. Mycoses. 2002;45(1–2):50–4.CrossRefPubMedGoogle Scholar
  27. 160.
    Keyser A, Schmid FX, Linde HJ, Merk J, Birnbaum DE. Disseminated Cladophialophora bantiana infection in a heart transplant recipient. J Heart Lung Transplant. 2002;21:503–5.CrossRefPubMedGoogle Scholar
  28. 161.
    Levy I, Stein J, Ashkenazi S, et al. Ecthyma gangrenosum caused by disseminated Exserohilum in a child with leukemia: case report and review of the literature. Pediatr Dermatol. 2003;20:495–7.CrossRefPubMedGoogle Scholar

Scedosporium and Pseudallescheria

  1. 162.
    Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21(1):157–97.CrossRefPubMedGoogle Scholar
  2. 163.
    Husain S, Muñoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40(1):89–99.CrossRefPubMedGoogle Scholar
  3. 164.
    Ginter G, de Hoog GS, Pschaid A, et al. Arthritis without grains caused by Pseudallescheria boydii. Mycoses. 1995;38(9–10):369–71.CrossRefPubMedGoogle Scholar
  4. 165.
    Bower CP, Oxley JD, Campbell CK, Archer CB. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient. J Clin Pathol. 1999;52(11):846–8.CrossRefPubMedGoogle Scholar
  5. 166.
    Lavigne C, Maillot F, de Muret A, et al. Cutaneous infection with Scedosporium apiospermum in a patient treated with corticosteroids. Acta Derm Venereol. 1999;79(5):402–3.CrossRefPubMedGoogle Scholar
  6. 167.
    Talbot TR, Hatcher J, Davis SF, et al. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation. 2002;74(11):1645–7.CrossRefPubMedGoogle Scholar
  7. 168.
    Lainscak M, Hocevar A, Logar D, et al. Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient. Clin Rheumatol. 2007;26:1023–4.CrossRefPubMedGoogle Scholar
  8. 169.
    Uenotsuchi T, Moroi Y, Urabe K, et al. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol. 2005;85(2):156–9.CrossRefPubMedGoogle Scholar
  9. 170.
    Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002;81(5):333–48.CrossRefGoogle Scholar
  10. 171.
    Chaveiro MA, Vieira R, Cardoso J, Afonso A. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient. J Eur Acad Dermatol Venereol. 2003;17(1):47–9.CrossRefPubMedGoogle Scholar
  11. 172.
    Shinohara MM, George E. Scedosporium apiospermum an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes. J Cutan Pathol. 2009;36 Suppl 1:39–41.CrossRefPubMedGoogle Scholar
  12. 173.
    Kusuhara M, Hachisuka H. Lymphocutaneous infection due to Scedosporium apiospermum. Int J Dermatol. 1997;36(9):684–8.CrossRefPubMedGoogle Scholar
  13. 174.
    Ruxin TA, Steck WD, Helm TN, Bergfeld WF, Bolwell BJ. Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole. Arch Dermatol. 1996;132(4):382–4.CrossRefPubMedGoogle Scholar
  14. 175.
    Hagari Y, Ishioka S, Ohyama F, Mihara M. Cutaneous infection showing sporotrichoid spread caused by Pseudallescheria boydii (Scedosporium apiospermum): successful detection of fungal DNA in formalin-fixed, paraffin-embedded sections by seminested PCR. Arch Dermatol. 2002;138(2):271–2.CrossRefPubMedGoogle Scholar
  15. 176.
    Török L, Simon G, Csornai A, Tápai M, Török I. Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukaemia. Br J Dermatol. 1995;133(5):805–9.CrossRefPubMedGoogle Scholar
  16. 177.
    Bernstein EF, Schuster MG, Stieritz DD, Heuman PC, Uitto J. Disseminated cutaneous Pseudallescheria boydii. Br J Dermato. 1995;132(3):456–60.CrossRefGoogle Scholar
  17. 178.
    Barbaric D, Shaw PJ. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole. Med Pediatr Oncol. 2001;37(2):122–5.CrossRefPubMedGoogle Scholar
  18. 179.
    Elm MK, Ahmed A, Gokselo D, Heming JS. Cutaneous and systemic infection with Scedosporium apiospermum. Cutis. 2009;84:275–8.PubMedGoogle Scholar
  19. 180.
    Berenguer J, Rodríguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore). 1997;76(4):256–65.CrossRefGoogle Scholar
  20. 181.
    Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47(4):359–70.CrossRefPubMedGoogle Scholar


  1. 182.
    Dong JA, Chren MM, Elewski BE. Bonsai tree: risk factor for disseminated sporotrichosis. J Am Acad Dermatol. 1995;33:839–40.CrossRefPubMedGoogle Scholar
  2. 183.
    Cohen PR, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.Google Scholar
  3. 184.
    Yang DJ, Krishnan RS, Guillen DR, et al. Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol. 2006;45:450–3.CrossRefPubMedGoogle Scholar
  4. 185.
    Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25(2):181–7.CrossRefPubMedGoogle Scholar
  5. 186.
    al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26(6):1403–6.CrossRefPubMedGoogle Scholar
  6. 187.
    Bonifaz A, Peniche A, Mercadillo P, Saúl A. Successful treatment of AIDS-related disseminated cutaneous sporotrichosis with itraconazole. AIDS Patient Care STDS. 2001;15(12):603–6.CrossRefPubMedGoogle Scholar
  7. 188.
    Carvalho MT, de Castro AP, Baby C, et al. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop. 2002;35(6):655–9.CrossRefPubMedGoogle Scholar
  8. 189.
    Sharma NL, Mehta KI, Mahajan VK, et al. Cutaneous sporotrichosis of face: polymorphism and reactivation after intralesional triamcinolone. Indian J Dermatol Venereol Leprol. 2007;73(3):188–90.CrossRefPubMedGoogle Scholar
  9. 190.
    Donabedian H, O’Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18(2):111–5.CrossRefPubMedGoogle Scholar
  10. 191.
    Yelverton CB, Stetson CL, Bang RH, Clark JW, Butler DF. Fatal sporotrichosis. Cutis. 2006;78(4):253–6.PubMedGoogle Scholar
  11. 192.
    Kim S, Rusk MH, James WD. Erysipeloid sporotrichosis in a woman with Cushing’s disease. J Am Acad Dermatol. 1999;40:272–4.CrossRefPubMedGoogle Scholar
  12. 193.
    Rocha MM, Dassin T, Lira R, et al. Sporotrichosis in patient with AIDS: report of a case and review. Rev Iberoam Micol. 2001;18(3):133–6.PubMedGoogle Scholar
  13. 194.
    Fontes PC, Kitakawa D, Carvalho YR, et al. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol. 2007;51(4):648–50.CrossRefPubMedGoogle Scholar
  14. 195.
    Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis. 2001;7(2):134–6.CrossRefPubMedGoogle Scholar
  15. 196.
    Johnson RA. HIV disease: mucocutaneous fungal infections in HIV disease. Clin Dermatol. 2000;18(4):411–22.CrossRefPubMedGoogle Scholar
  16. 197.
    Silva-Vergara ML, Maneira FR, De Oliveira RM, et al. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol. 2005;43(2):187–90.CrossRefPubMedGoogle Scholar
  17. 198.
    Severo LC, Festugato M, Bernardi C, Londero AT. Widespread cutaneous lesions due to Sporothrix schenckii in a patient under a long-term steroids therapy. Rev Inst Med Trop Sao Paulo. 1999;41(1):59–62.CrossRefPubMedGoogle Scholar
  18. 199.
    Hardman S, Stephenson I, Jenkins DR, Wiselka MJ, Johnson EM. Disseminated Sporothix schenckii in a patient with AIDS. J Infect. 2005;51(3):e73–7.CrossRefPubMedGoogle Scholar
  19. 200.
    Vilela R, Souza GF, Fernandes Cota G, Mendoza L. Cutaneous and meningeal sporotrichosis in a HIV patient. Rev Iberoam Micol. 2007;24(2):161–3.CrossRefPubMedGoogle Scholar
  20. 201.
    Bickley LK, Berman IJ, Hood AF. Fixed cutaneous ­sporotrichosis: unusual histopathology following intralesional corticosteroid administration. J Am Acad Dermatol. 1985;12(6):1007–12.CrossRefPubMedGoogle Scholar
  21. 202.
    Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol. 1999;40(2 Pt 2):350–5.CrossRefPubMedGoogle Scholar


  1. 203.
    Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: a case of mucormycosis. Cutis. 2000;66(1):15–8.PubMedGoogle Scholar
  2. 204.
    Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol. 1994;30(5 Pt 2):904–8.CrossRefPubMedGoogle Scholar
  3. 205.
    Samant JS, Namgoong SH, Parveen T, Katner HP. Cytomegalovirus vasculitis and mucormycosis coinfection in late-stage HIV/AIDS. Am J Med Sci. 2007;333(2):122–4.CrossRefPubMedGoogle Scholar
  4. 206.
    Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet. 1996;348(9025):441–3.CrossRefPubMedGoogle Scholar
  5. 207.
    Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol. 2007;139(4):519–31.CrossRefPubMedGoogle Scholar
  6. 208.
    Ramos A, Cuervas-Mons V, Noblejas A, et al. Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc. 2009;41(5):1972–5.CrossRefPubMedGoogle Scholar
  7. 209.
    Fujimoto A, Nagao K, Tanaka K, et al. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus. Br J Dermatol. 2005;153(2):428–30.CrossRefPubMedGoogle Scholar
  8. 210.
    Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:15–20.CrossRefPubMedGoogle Scholar
  9. 211.
    Takabayashi M, Sakai R, Sakamoto H, et al. Cutaneous mucormycosis during induction chemotherapy for acute lymphocytic leukemia. Leuk Lymphoma. 2004;45(1):199–200.CrossRefPubMedGoogle Scholar
  10. 212.
    Wirth F, Perry R, Eskenazi A, Schwalbe R, Kao G. Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature. J Am Acad Dermatol. 1997;36(2 Pt 2):336–41.CrossRefPubMedGoogle Scholar
  11. 213.
    Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.CrossRefPubMedGoogle Scholar
  12. 214.
    Rubin AI, Grossman ME. Bull’s-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol. 2004;51:996–1001.CrossRefPubMedGoogle Scholar
  13. 215.
    Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth. 2002;49(8):880–2.CrossRefPubMedGoogle Scholar
  14. 216.
    Woods SG, Elewski BE. Zosteriform zygomycosis. J Am Acad Dermatol. 1995;32(2 Pt 2):357–61.CrossRefPubMedGoogle Scholar
  15. 217.
    Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:41–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Marc E. Grossman
    • 1
  • Lindy P. Fox
    • 2
  • Carrie Kovarik
    • 3
  • Misha Rosenbach
    • 4
  1. 1.New York Presbyterian HospitalColumbia University Medical CenterNew YorkUSA
  2. 2.University of California, San FranciscoSan FranciscoUSA
  3. 3.Dermatopathology, and Infectious DiseasesUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations